[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
Abroad (travel likely)RecruitingPHASE1
Conditions
Sinonasal Neuroendocrine Carcinoma · Nasopharyngeal Carcinoma · Esthesioneuroblastoma · Olfactory Neuroblastoma · Somatostatin Receptor Positive · Small Cell Lung Cancers · Pheochromocytoma/Paragangliomas · Kidney Cancers · Head and Neck Tumors · Gastrointestinal Neuroendocrine Tumors
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (National Cancer Institute Referral Office) · ncimo_referrals@mail.nih.gov · 888-624-1937
Study leads
Frank I Lin, M.D.
Principal Investigator
National Cancer Institute (NCI)